{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:07:34Z","timestamp":1652090854023},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Hist"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10735-009-9213-6","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T15:32:27Z","timestamp":1236353547000},"page":"81-86","source":"Crossref","is-referenced-by-count":3,"title":["Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"40","author":[{"given":"Petra","family":"Kora\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radmila","family":"Ajdukovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana Mariana","family":"Kardum Paro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branimir","family":"Jak\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Dominis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"9213_CR1","doi-asserted-by":"crossref","unstructured":"Binet JL, Auquier A, Dighiero G et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198\u2013206. doi: 10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"9213_CR2","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2005-03-1099","volume":"106","author":"JE Castro","year":"2005","unstructured":"Castro JE, Prada CE, Loria O et al (2005) ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood 106:2506\u20132512. doi: 10.1182\/blood-2005-03-1099","journal-title":"Blood"},{"key":"9213_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1600-0609.2005.00619.x","volume":"76","author":"MA Catherwood","year":"2006","unstructured":"Catherwood MA, Matthews C, Niblock R et al (2006) ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haematol 76:294\u2013298. doi: 10.1111\/j.1600-0609.2005.00619.x","journal-title":"Eur J Haematol"},{"key":"9213_CR4","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","volume":"100","author":"L Chen","year":"2002","unstructured":"Chen L, Widhopf G, Huynh L et al (2002) Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100:4609\u20134614. doi: 10.1182\/blood-2002-06-1683","journal-title":"Blood"},{"key":"9213_CR5","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M et al (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990\u20134997","journal-title":"Blood"},{"key":"9213_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.0007-1048.2001.3205.x","volume":"116","author":"P Chevallier","year":"2002","unstructured":"Chevallier P, Penther D, Avet-Loiseau H et al (2002) CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphyocytic leukaemia. Br J Haematol 116:142\u2013150. doi: 10.1046\/j.0007-1048.2001.3205.x","journal-title":"Br J Haematol"},{"key":"9213_CR7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804\u2013815. doi: 10.1056\/NEJMra041720","journal-title":"N Engl J Med"},{"key":"9213_CR8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N et al (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764\u20131775. doi: 10.1056\/NEJMoa023143","journal-title":"N Engl J Med"},{"key":"9213_CR9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840\u20131847","journal-title":"Blood"},{"key":"9213_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10428190109097682","volume":"42","author":"G D\u2019Arena","year":"2001","unstructured":"D\u2019Arena G, Musto P, Cascavilla N et al (2001) CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 42:109\u2013114. doi: 10.3109\/10428190109097682","journal-title":"Leuk Lymphoma"},{"key":"9213_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","volume":"16","author":"J D\u00fcrig","year":"2002","unstructured":"D\u00fcrig J, Naschar M, Schm\u00fccker U et al (2002) CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 16:30\u201335. doi: 10.1038\/sj.leu.2402339","journal-title":"Leukemia"},{"key":"9213_CR12","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/sj.leu.2403147","volume":"17","author":"J D\u00fcrig","year":"2003","unstructured":"D\u00fcrig J, N\u00fcckel H, Cremer M et al (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 17:2426\u20132434. doi: 10.1038\/sj.leu.2403147","journal-title":"Leukemia"},{"key":"9213_CR13","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2002-06-1801","volume":"101","author":"P Ghia","year":"2003","unstructured":"Ghia P, Guida G, Stella S et al (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 101:1262\u20131269. doi: 10.1182\/blood-2002-06-1801","journal-title":"Blood"},{"key":"9213_CR14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.V95.7.2455","volume":"95","author":"TJ Hamblin","year":"2000","unstructured":"Hamblin TJ, Orchard JA, Gardiner A et al (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood 95:2455\u20132457","journal-title":"Blood"},{"key":"9213_CR15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","volume":"99","author":"TJ Hamblin","year":"2002","unstructured":"Hamblin TJ, Orchard JA, Ibbotson RE et al (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 99:1023\u20131029. doi: 10.1182\/blood.V99.3.1023","journal-title":"Blood"},{"key":"9213_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","volume":"98","author":"S Ibrahim","year":"2001","unstructured":"Ibrahim S, Keating M, Do KA et al (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98:181\u2013186. doi: 10.1182\/blood.V98.1.181","journal-title":"Blood"},{"key":"9213_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.1981.tb07243.x","volume":"49","author":"B Jaksic","year":"1981","unstructured":"Jaksic B, Vitale B (1981) Total tumour mass score (TTM): a new parameter in chronic lymphocyte leukaemia. Br J Haematol 49:405\u2013413. doi: 10.1111\/j.1365-2141.1981.tb07243.x","journal-title":"Br J Haematol"},{"key":"9213_CR18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","volume":"115","author":"DF Jelinek","year":"2001","unstructured":"Jelinek DF, Tschumper RC, Geyer SM et al (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 115:854\u2013861. doi: 10.1046\/j.1365-2141.2001.03149.x","journal-title":"Br J Haematol"},{"key":"9213_CR19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"A Krober","year":"2002","unstructured":"Krober A, Seiler T, Benner A et al (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410\u20131416","journal-title":"Blood"},{"key":"9213_CR20","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2001-11-0066","volume":"100","author":"K Lin","year":"2002","unstructured":"Lin K, Sherrington PD, Dennis M et al (2002) Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100:1404\u20131409. doi: 10.1182\/blood-2001-11-0066","journal-title":"Blood"},{"key":"9213_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2141.2002.03673.x","volume":"118","author":"T Mainou-Fowler","year":"2002","unstructured":"Mainou-Fowler T, Dignum H, Taylor PR et al (2002) Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia. Br J Haematol 118:755\u2013761. doi: 10.1046\/j.1365-2141.2002.03673.x","journal-title":"Br J Haematol"},{"key":"9213_CR22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.V97.6.1902","volume":"97","author":"Z Matrai","year":"2001","unstructured":"Matrai Z, Lin K, Dennis M et al (2001) CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood 97:1902\u20131903. doi: 10.1182\/blood.V97.6.1902","journal-title":"Blood"},{"key":"9213_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","volume":"46","author":"KR Rai","year":"1975","unstructured":"Rai KR, Sawitsky A, Cronkite EP et al (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219\u2013234","journal-title":"Blood"},{"key":"9213_CR24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti LZ, Huynh L, Toy TL et al (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor o disease progression in chronic lymphocytic leukia. N Engl J Med 351:893\u2013901. doi: 10.1056\/NEJMoa040857","journal-title":"N Engl J Med"},{"key":"9213_CR25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2141.2005.05919.x","volume":"132","author":"KS Reddy","year":"2006","unstructured":"Reddy KS (2006) Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol 132:705\u2013722. doi: 10.1111\/j.1365-2141.2005.05919.x","journal-title":"Br J Haematol"},{"key":"9213_CR26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood-2003-07-2281","volume":"103","author":"TD Shanafelt","year":"2004","unstructured":"Shanafelt TD, Geyer SM, Kay NE (2004) Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 103:1202\u20131210. doi: 10.1182\/blood-2003-07-2281","journal-title":"Blood"},{"key":"9213_CR27","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","volume":"103","author":"FK Stevenson","year":"2004","unstructured":"Stevenson FK, Caligaris-Cappio F (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103:4389\u20134395. doi: 10.1182\/blood-2003-12-4312","journal-title":"Blood"},{"key":"9213_CR28","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS et al (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944\u20134951. doi: 10.1182\/blood-2002-10-3306","journal-title":"Blood"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-009-9213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10735-009-9213-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-009-9213-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:42:46Z","timestamp":1589632966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10735-009-9213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["9213"],"URL":"https:\/\/doi.org\/10.1007\/s10735-009-9213-6","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}